The Vanguard Group's Disclosure on Spire Healthcare Stake

The Vanguard Group, Inc. has released a Form 8.3 regarding its stake in Spire Healthcare Group plc. As of July 22, 2026, Vanguard controls 3.54% of Spire's ordinary shares, amounting to 14,274,494 shares. This information is part of the disclosure requirements for entities with significant securities interests under Rule 8.3 of the Takeover Code.

The disclosure outlines that Vanguard made a small sale of 1,470 shares at a price of 2.22 GBP per share. No cash-settled or stock-settled derivative transactions, nor any significant dealings in other classes of Spire's securities, were reported. Furthermore, the report confirms a lack of indemnity or other dealing arrangements that could influence transactions. The document concludes by confirming that no supplemental forms were attached.